Aspects of human cytomegalovirus latency and reactivation.
about
Genomic and functional characteristics of human cytomegalovirus revealed by next-generation sequencingNeutralizing antibodies against previously encountered influenza virus strains increase over time: a longitudinal analysis.Cytomegalovirus: pathogen, paradigm, and puzzleBiphasic recruitment of transcriptional repressors to the murine cytomegalovirus major immediate-early promoter during the course of infection in vivoCytomegalovirus latency and reactivation: recent insights into an age old problem.Human cytomegalovirus IE1 protein elicits a type II interferon-like host cell response that depends on activated STAT1 but not interferon-γCytomegalovirus infection in pediatric rheumatic diseases: a review.Current knowledge of MicroRNAs and noncoding RNAs in virus-infected cells.Virus vasculopathy and stroke: an under-recognized cause and treatment target.The longevity of memory CD8 T cell responses after repetitive antigen stimulationsRepetitive antigen stimulation induces stepwise transcriptome diversification but preserves a core signature of memory CD8(+) T cell differentiation.Role of noncovalent SUMO binding by the human cytomegalovirus IE2 transactivator in lytic growth.Human cytomegalovirus tropism for mucosal myeloid dendritic cells.Recombinant human cytomegalovirus (HCMV) RL13 binds human immunoglobulin G Fc.HCMV protein LUNA is required for viral reactivation from latently infected primary CD14⁺ cells.Murine cytomegalovirus immediate-early 1 gene expression correlates with increased GVHD after allogeneic hematopoietic cell transplantation in recipients reactivating from latent infection.VIPhyb, an antagonist of vasoactive intestinal peptide receptor, enhances cellular antiviral immunity in murine cytomegalovirus infected mice.Identification of a neutralizing epitope within antigenic domain 5 of glycoprotein B of human cytomegalovirus.Cytomegalovirus reactivation in critically ill immunocompetent hosts: a decade of progress and remaining challenges.Reversible silencing of cytomegalovirus genomes by type I interferon governs virus latency.Human cytomegalovirus primase UL70 specifically interacts with cellular factor Snapin.NK cells and immune "memory"Adaptive Natural Killer Cell and Killer Cell Immunoglobulin-Like Receptor-Expressing T Cell Responses are Induced by Cytomegalovirus and Are Associated with Protection against Cytomegalovirus Reactivation after Allogeneic Donor Hematopoietic Cell TrThe life cycle and pathogenesis of human cytomegalovirus infection: lessons from proteomicsThe host ubiquitin-dependent segregase VCP/p97 is required for the onset of human cytomegalovirus replication.Human cytomegalovirus UL97 kinase alters the accumulation of CDK1.Intensity of the humoral response to cytomegalovirus is associated with the phenotypic and functional status of the immune system.Utility of the Enzyme-Linked Immunospot Interferon-γ-Release Assay to Predict the Risk of Cytomegalovirus Infection in Hematopoietic Cell Transplant Recipients.Human embryonic stem cell lines model experimental human cytomegalovirus latency.Epigenetic control of cytomegalovirus latency and reactivation.The mouse cytomegalovirus immediate-early 1 gene is not required for establishment of latency or for reactivation in the lungs.HIV interactions with monocytes and dendritic cells: viral latency and reservoirs.Liver sinusoidal endothelial cells are a site of murine cytomegalovirus latency and reactivationMultifaceted evasion of the interferon response by cytomegalovirus.The tiers and dimensions of evasion of the type I interferon response by human cytomegalovirus.Human cytomegalovirus UL76 induces chromosome aberrations.Cytomegalovirus hijacks CX3CR1(hi) patrolling monocytes as immune-privileged vehicles for dissemination in miceChromatin-mediated regulation of cytomegalovirus gene expression.Tale of a tegument transactivator: the past, present and future of human CMV pp71Regulation of human cytomegalovirus transcription in latency: beyond the major immediate-early promoter
P2860
Q28541706-F348A61C-DFCD-4E0F-83CB-32155552902EQ30352862-0EEBC331-0D8E-46AE-9483-69C1ED243F48Q33351523-FAF16783-3740-4CFC-998B-8CACA76D324AQ33725662-440856F5-6900-44B9-B259-5CDE96E56BE1Q33761454-3C433327-A469-4598-91F5-11B6880F81B8Q33886711-93C151F1-ADA2-4C99-9A16-283F77155C45Q33912101-D9454103-E9A2-44C7-9099-2DA7EE0B02BDQ34003311-9C4C51AF-D537-4EC6-9C26-BB065FDD5536Q34015853-8D53863E-4BA4-49DC-8D19-E7715C252F97Q34024434-AB16C27A-1A82-4EFF-BBC8-846DB45C35BBQ34028816-3B9E8BF4-983A-4BBA-A28D-D39206F53554Q34046161-A855B0F9-2BF5-4394-823D-80D59396F180Q34422068-77332733-8390-4A2F-A302-0B898845E708Q34505169-55C335EC-E6F9-42ED-8142-6DEB274FA396Q34541265-34EA3EC0-E32B-409E-923B-18CFB5B17C8DQ34676355-8E82F8ED-4B34-4F2C-AE4A-70CB360AFC53Q34749251-F5184F62-B652-4437-A21E-5EADC20709C1Q34992770-4B4E67D9-F7DA-4C45-9FC4-E183D5AA57CFQ35086196-B91A6688-3E30-4742-89D4-8FD09271016EQ35105651-E448B349-DD23-4D23-83C6-E44F088BC567Q35531256-35CE8209-AD66-4B28-B95E-544A8A3ED77EQ35539280-13060DC7-AEAC-44E7-AB3E-6D2BD3D05A4CQ36020519-006D88BA-3F89-488F-BEB5-27C3C34F86A8Q36159634-13D75EBF-2AAC-4EED-9608-A7545ED2CA21Q36369230-8A6AFF98-E878-4981-85FF-AF9A41CB45C0Q36523126-A2E60FA4-DB9E-4C79-93D1-78507ABAFCF0Q36760142-CE9D1532-D5A4-4780-85AB-C029346A0961Q36871982-CF4BA3DB-B740-42D6-AE5E-59AB7D470EB5Q36873797-F01C4E45-9620-458B-95EF-9181392BEE87Q37015743-E5F9DCAB-03AA-432E-A167-97BAA0739A4FQ37157169-8EBA5B84-6E7A-4EB2-84AA-619A9BFD1EEFQ37229398-01D13802-E7F3-4480-99EE-D63CCD1A52CFQ37333761-FEF035E0-62AB-4C9C-AA22-ECCD058DF8ADQ37346283-C579C4F3-B39E-40F1-9067-DB8AE31C94EFQ37395985-8726AEE5-ECCD-4032-8B65-2F4AC745EDC0Q37458701-EACA4D8E-BA86-4556-8F82-ED641EB22AC6Q37706830-0E42FB66-FA4A-4470-89C1-9AD6DA344C8DQ37793472-EF7834B8-12C5-4577-9B0C-C039D9D7FBD9Q38078937-6BCFD6CA-F42D-463C-8F7D-64517884B023Q38111995-D3EDE987-BB32-4EAE-9761-725B372B3904
P2860
Aspects of human cytomegalovirus latency and reactivation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Aspects of human cytomegalovirus latency and reactivation.
@en
Aspects of human cytomegalovirus latency and reactivation.
@nl
type
label
Aspects of human cytomegalovirus latency and reactivation.
@en
Aspects of human cytomegalovirus latency and reactivation.
@nl
prefLabel
Aspects of human cytomegalovirus latency and reactivation.
@en
Aspects of human cytomegalovirus latency and reactivation.
@nl
P1476
Aspects of human cytomegalovirus latency and reactivation.
@en
P2093
P304
P577
2008-01-01T00:00:00Z